60 related articles for article (PubMed ID: 22522791)
1. Evidence for a protective role of the STAT5 transcription factor against oxidative stress in human leukemic pre-B cells.
Cholez E; Debuysscher V; Bourgeais J; Boudot C; Leprince J; Tron F; Brassart B; Regnier A; Bissac E; Pecnard E; Gouilleux F; Lassoued K; Gouilleux-Gruart V
Leukemia; 2012 Nov; 26(11):2390-7. PubMed ID: 22522791
[TBL] [Abstract][Full Text] [Related]
2. STAT5 isoforms regulate colorectal cancer cell apoptosis via reduction of mitochondrial membrane potential and generation of reactive oxygen species.
Du W; Wang YC; Hong J; Su WY; Lin YW; Lu R; Xiong H; Fang JY
J Cell Physiol; 2012 Jun; 227(6):2421-9. PubMed ID: 21826656
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-7 induces apoptosis of 697 pre-B cells expressing dominant-negative forms of STAT5: evidence for caspase-dependent and -independent mechanisms.
Lanvin O; Gouilleux F; Mullié C; Mazière C; Fuentes V; Bissac E; Dantin F; Mazière JC; Régnier A; Lassoued K; Gouilleux-Gruart V
Oncogene; 2004 Apr; 23(17):3040-7. PubMed ID: 15048088
[TBL] [Abstract][Full Text] [Related]
4. Bruton's tyrosine kinase prevents activation of the anti-apoptotic transcription factor STAT3 and promotes apoptosis in neoplastic B-cells and B-cell precursors exposed to oxidative stress.
Uckun F; Ozer Z; Vassilev A
Br J Haematol; 2007 Feb; 136(4):574-89. PubMed ID: 17367410
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of Bcr-Abl kinase activity by PD180970 blocks constitutive activation of Stat5 and growth of CML cells.
Huang M; Dorsey JF; Epling-Burnette PK; Nimmanapalli R; Landowski TH; Mora LB; Niu G; Sinibaldi D; Bai F; Kraker A; Yu H; Moscinski L; Wei S; Djeu J; Dalton WS; Bhalla K; Loughran TP; Wu J; Jove R
Oncogene; 2002 Dec; 21(57):8804-16. PubMed ID: 12483533
[TBL] [Abstract][Full Text] [Related]
6. STAT5a-targeting miRNA enhances chemosensitivity to cisplatin and 5-fluorouracil in human colorectal cancer cells.
Hong X; Chen G; Wang M; Lou C; Mao Y; Li Z; Zhang Y
Mol Med Rep; 2012 May; 5(5):1215-9. PubMed ID: 22367509
[TBL] [Abstract][Full Text] [Related]
7. Constitutive activation of Flt3 and STAT5A enhances self-renewal and alters differentiation of hematopoietic stem cells.
Moore MA; Dorn DC; Schuringa JJ; Chung KY; Morrone G
Exp Hematol; 2007 Apr; 35(4 Suppl 1):105-16. PubMed ID: 17379095
[TBL] [Abstract][Full Text] [Related]
8. IL-3 dependent regulation of Bcl-xL gene expression by STAT5 in a bone marrow derived cell line.
Dumon S; Santos SC; Debierre-Grockiego F; Gouilleux-Gruart V; Cocault L; Boucheron C; Mollat P; Gisselbrecht S; Gouilleux F
Oncogene; 1999 Jul; 18(29):4191-9. PubMed ID: 10435632
[TBL] [Abstract][Full Text] [Related]
9. A role for STAT5A/B in protection of peripheral T-lymphocytes from postactivation apoptosis: insights from gene expression profiling.
Gatzka M; Piekorz R; Moriggl R; Rawlings J; Ihle JN
Cytokine; 2006 May; 34(3-4):143-54. PubMed ID: 16757175
[TBL] [Abstract][Full Text] [Related]
10. Role of reactive oxygen species, glutathione and NF-kappaB in apoptosis induced by 3,4-methylenedioxymethamphetamine ("Ecstasy") on hepatic stellate cells.
Montiel-Duarte C; Ansorena E; López-Zabalza MJ; Cenarruzabeitia E; Iraburu MJ
Biochem Pharmacol; 2004 Mar; 67(6):1025-33. PubMed ID: 15006539
[TBL] [Abstract][Full Text] [Related]
11. STAT5 as a molecular regulator of proliferation, differentiation and apoptosis in hematopoietic cells.
Nosaka T; Kawashima T; Misawa K; Ikuta K; Mui AL; Kitamura T
EMBO J; 1999 Sep; 18(17):4754-65. PubMed ID: 10469654
[TBL] [Abstract][Full Text] [Related]
12. Constitutive STAT5 activation specifically cooperates with the loss of p53 function in B-cell lymphomagenesis.
Joliot V; Cormier F; Medyouf H; Alcalde H; Ghysdael J
Oncogene; 2006 Aug; 25(33):4573-84. PubMed ID: 16532027
[TBL] [Abstract][Full Text] [Related]
13. Downregulation of signal transducer and activator of transcription 5 (STAT5) in CD34+ cells promotes megakaryocytic development, whereas activation of STAT5 drives erythropoiesis.
Olthof SG; Fatrai S; Drayer AL; Tyl MR; Vellenga E; Schuringa JJ
Stem Cells; 2008 Jul; 26(7):1732-42. PubMed ID: 18436865
[TBL] [Abstract][Full Text] [Related]
14. Naturally occurring dominant-negative Stat5 suppresses transcriptional activity of estrogen receptors and induces apoptosis in T47D breast cancer cells.
Yamashita H; Iwase H; Toyama T; Fujii Y
Oncogene; 2003 Mar; 22(11):1638-52. PubMed ID: 12642867
[TBL] [Abstract][Full Text] [Related]
15. Interleukin-2 family cytokines stimulate phosphorylation of the Pro-Ser-Pro motif of Stat5 transcription factors in human T cells: resistance to suppression of multiple serine kinase pathways.
Nagy ZS; Wang Y; Erwin-Cohen RA; Aradi J; Monia B; Wang LH; Stepkowski SM; Rui H; Kirken RA
J Leukoc Biol; 2002 Oct; 72(4):819-28. PubMed ID: 12377952
[TBL] [Abstract][Full Text] [Related]
16. Constitutively active STAT5A and STAT5B in vitro and in vivo: mutation of STAT5 is not a frequent cause of leukemogenesis.
Yamada K; Ariyoshi K; Onishi M; Miyajima A; Hayakawa F; Towatari M; Saito H; Oka Y; Asano S; Nosaka T; Kitamura T
Int J Hematol; 2000 Jan; 71(1):46-54. PubMed ID: 10729993
[TBL] [Abstract][Full Text] [Related]
17. RNAi-mediated silencing of p190Bcr-Abl inactivates Stat5 and cooperates with imatinib mesylate and 17-allylamino-17-demetoxygeldanamycin in selective killing of p190Bcr-Abl-expressing leukemia cells.
Futami M; Hatano T; Soda Y; Kobayashi S; Miyagishi M; Tojo A
Leukemia; 2008 Jun; 22(6):1131-8. PubMed ID: 18368071
[TBL] [Abstract][Full Text] [Related]
18. Antiapoptotic activity of Stat5 required during terminal stages of myeloid differentiation.
Kieslinger M; Woldman I; Moriggl R; Hofmann J; Marine JC; Ihle JN; Beug H; Decker T
Genes Dev; 2000 Jan; 14(2):232-44. PubMed ID: 10652277
[TBL] [Abstract][Full Text] [Related]
19. A novel antioxidant N-acetylcysteine amide prevents gp120- and Tat-induced oxidative stress in brain endothelial cells.
Price TO; Uras F; Banks WA; Ercal N
Exp Neurol; 2006 Sep; 201(1):193-202. PubMed ID: 16750528
[TBL] [Abstract][Full Text] [Related]
20. STAT5 in B cell development and leukemia.
Malin S; McManus S; Busslinger M
Curr Opin Immunol; 2010 Apr; 22(2):168-76. PubMed ID: 20227268
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]